Letters

Stockpiling oseltamivir: Roche clarifies data for improved mortality with oseltamivir

BMJ 2005; 331 doi: http://dx.doi.org/10.1136/bmj.331.7526.1203-b (Published 17 November 2005) Cite this as: BMJ 2005;331:1203
  1. James R Smith ([email protected]), international medical leader,
  2. Regina Dutkowski, clinical science leader
  1. F Hoffman-La Roche, CH-4070 Basel, Switzerland
  2. Hoffmann-La Roche, Nutley, NJ 07110, USA

    EDITOR—Experts question the wisdom of stockpiling oseltamivir (Tamiflu).1 A question was asked about data supporting an improvement in mortality with the drug.

    Two datasets were presented at the second European Influenza Conference in Malta (http://www.eswi.org/) in September. A large retrospective cohort study of patients with influenza-like illness (n= 176 001) taken from a US health database showed …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe